FdaApplication

NDA 021937

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGILEAD SCIENCES LLC
application_typeNDA
approval_date2006-07-12

Products (1)

ProductActive ingredientStrengthDosage form
ATRIPLAEFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE600MG;200MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL

1 product